Activated T Cells armed with GD2 Bispecific Antibody
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Activated T Cells armed with GD2 Bispecific Antibody, covering 2019-01-29 to 2019-01-29. Get the full timeline:
Most recent: Clinical Trial Update: Activated T Cells Armed With GD2 Bispecific Antibody in Children and Young Adults With Neuroblastoma and Osteosarcoma [Phase 1, Phase 2]